MLTX

MoonLake Immunotherapeutics Class A Ordinary Shares
Data: 2026-09-04
Quick Stats
Sep 04, 2026

57.4

AI Score

HOLD

1.19

Volume Ratio

TBA

Next Earnings

12

+ve Days (30d)

18

-ve Days (30d)

MLTX Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

MLTX Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

MLTX Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MLTX Daily Out of Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MLTX Daily In the Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MLTX Most Active Options by Volume(near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track
MLTX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

MLTX Stock Summary

Last updated Sep 04, 2026

MLTX is currently trading at $15.01, positioned below its 200-day moving average of $16.9, suggesting bearish momentum. The stock has a 52-week range of $5.95 to $62.75.

Technical Analysis: The 50-day moving average stands at $17.82, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 34.267, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.077, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MLTX at 57.4/100 with a HOLD recommendation.

MLTX (MoonLake Immunotherapeutics Class A Ordinary Shares) Indicators

Last updated Sep 04, 2026

Indicator Value
RSI(14) 34.267
CMF (20) -0.077
ROC (10) -4.759
ADX (14) 31.559
Indicator Value
MACD (12,26,9) -0.809
AROONOSC (14) -57.143
WILLAMS %R (14) -82.928
MFI (14) 40.797

MoonLake Immunotherapeutics Class A Ordinary Shares is below both the 50 Day and 200 Day SMA which is considered Bearish.

MLTX Moving Averages Analysis

MLTX (MoonLake Immunotherapeutics Class A Ordinary Shares) Simple Moving Averages

Moving Averages are last updated Sep 04, 2026

Days MA
10 15.25
20 15.88
30 16.71
50 17.82
100 17.95
200 16.9

MLTX Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 1.3 billion
Earnings/Share ($) -3.84
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.33
EPS Estimate Next Year ($) -3.3421
WallStreet Target Price ($) 28.54
Most Recent Quarter

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.